Skip to content
NewA calmer, faster ZeroHour

OpenAI introduces MedChemBench for medicinal chemistry reasoning

Original title: Can AI help scientists identify promising drug candidates?

OpenAI News ()7 min read
Part of a story covered by 6 sourcesOpenAI releases GPT-6.2 Astra and Sol with cheaper Astra API pricingMerged summary & timeline
AI summary · x-ai/grok-4.7Summaries by Vani AI

Ninety-nine problems from 117 papers grade structure and property prediction; GPT-6.2 Astra scored 84.5%.

OpenAI released MedChemBench, a benchmark that tests whether models connect molecular structures with experimental evidence, explain results, compare compounds, and predict properties. It includes 99 problems, 761 molecular structures, and material from 117 papers and patents. At the xhigh setting, GPT-6.2 Astra scored 84.5%, ahead of GPT-6 Astra at 83.3% and GPT-5.6 Sol at 58.2%.

Unconfirmed: Scores are OpenAI's reported results on its own benchmark.

Key facts
  • Graded areas are structures, reasoning, ranking and selection, and property predictions.
  • GPT-6 Astra led at reconstructing structures and explaining experimental evidence.
  • Selecting compounds and predicting numerical properties was harder for GPT-6 Astra.
  • GPT-6 Astra rebuilt one 18-atom-ring compound correctly in all ten responses.
Explain this AI news with Vani AIWhat was announced, what is new and why it matters, in a new chat

From the original article

7 min read at openai.com

MedChemBench evaluates how well AI models interpret molecular structures, reason from experimental evidence, and select compounds in early drug discovery.

A short excerpt; the article and its images belong to the publisher. Summary, key facts and assessment above are AI-written from the article and can be wrong.